% Expired Patents = 50.0

Forward Citations = 17

Loading Chart...

5 inventors (with patents filed for the assignee):

Alcide Barberis (4 out of 22 patents)

Dominik Escher (3 out of 14 patents)

Adrian Auf Der Maur (2 out of 17 patents)

4. Tea Gunde (1 out of 27 patents)

5. Catherine Berset (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 7566528 - Method for the identification and/or validation of receptor tyrosine kinase inhibitors (2009-07-28),

2. 7258986 - Intrabodies with defined framework that is stable in a reducing environment and applications thereof (2007-08-21),

3. 7258985 - Intrabodies with defined framework that is stable in a reducing environment and applications thereof (2007-08-21),

4. 6821728 - Screening system (2004-11-23),

Company Overview

Esbatech Ag is a leading provider of innovative solutions for the pharmaceutical industry. With a focus on cutting-edge technology and research, Esbatech Ag offers a range of products and services to support drug development and manufacturing processes. The company's expert team is dedicated to delivering high-quality solutions that meet the needs of clients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#23 in Schlieren

#2,006 in Switzerland

Schlieren, Switzerland

Esbatech Ag

Forward Citations = 17

5 inventors:

Alcide Barberis (4 out of 22 patents)

Dominik Escher (3 out of 14 patents)

Adrian Auf Der Maur (2 out of 17 patents)

4. Tea Gunde (1 out of 27 patents)

5. Catherine Berset (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Esbatech Ag. Retrieved from https://idiyas.com/company/esbatech-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]